These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12197927)

  • 1. Comorbidities in patients with end-stage renal disease in developing countries.
    Eiam-Ong S; Sitprija V
    Artif Organs; 2002 Sep; 26(9):753-6. PubMed ID: 12197927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UK Renal Registry 13th Annual Report (December 2010): Chapter 4: comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland from 2008 to 2009.
    Webb L; Gilg J; Feest T; Fogarty D
    Nephron Clin Pract; 2011; 119 Suppl 2():c85-96. PubMed ID: 21894042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can we improve early mortality in patients receiving renal replacement therapy?
    Metcalfe W; Khan IH; Prescott GJ; Simpson K; MacLeod AM
    Kidney Int; 2000 Jun; 57(6):2539-45. PubMed ID: 10844623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview: end-stage renal disease in the developing world.
    Barsoum RS
    Artif Organs; 2002 Sep; 26(9):737-46. PubMed ID: 12197924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Challenge of Providing Renal Replacement Therapy in Developing Countries: The Latin American Perspective.
    Obrador GT; Rubilar X; Agazzi E; Estefan J
    Am J Kidney Dis; 2016 Mar; 67(3):499-506. PubMed ID: 26709109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbidity ascertainment from the ESRD Medical Evidence Report and Medicare claims around dialysis initiation: a comparison using US Renal Data System data.
    Krishnan M; Weinhandl ED; Jackson S; Gilbertson DT; Lacson E
    Am J Kidney Dis; 2015 Nov; 66(5):802-12. PubMed ID: 26015277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Predictors of early death during dialysis].
    Caravaca F; Arrobas M; Pizarro JL; Cancho B; Cubero JJ; Espárrago JF; García MC; Sánchez-Casado E
    Nefrologia; 2001; 21(3):274-82. PubMed ID: 11471308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UK Renal Registry 16th annual report: chapter 5 comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland from 2011 to 2012.
    Rao A; Steenkamp R; Caskey F
    Nephron Clin Pract; 2013; 125(1-4):99-110. PubMed ID: 24662169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chapter 4 Comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland from 2009 to 2010.
    Shaw C; Webb L; Casula A; Tomson CR
    Nephron Clin Pract; 2012; 120 Suppl 1():c81-91. PubMed ID: 22964575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gap between estimated incidence of end-stage renal disease and use of therapy.
    Anand S; Bitton A; Gaziano T
    PLoS One; 2013; 8(8):e72860. PubMed ID: 24023651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. End-stage renal disease in Indonesia: treatment development.
    Prodjosudjadi W; Suhardjono A
    Ethn Dis; 2009; 19(1 Suppl 1):S1-33-6. PubMed ID: 19484872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. End-stage renal disease care in South Asia: demographics, economics, and opportunities.
    Kumar V; Jha V
    Clin Nephrol; 2016 Supplement 1; 86 (2016)(13):23-26. PubMed ID: 27469146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between attributed cause of end-stage renal disease and risk of death in Brazilian patients receiving renal replacement therapy.
    Batista PB; Lopes AA; Costa FA
    Ren Fail; 2005; 27(6):651-6. PubMed ID: 16350813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Has the incidence of end-stage renal disease in the USA and other countries stabilized?
    Eggers PW
    Curr Opin Nephrol Hypertens; 2011 May; 20(3):241-5. PubMed ID: 21422925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of end-stage renal disease in Iran: a review article.
    Mousavi SS; Soleimani A; Mousavi MB
    Saudi J Kidney Dis Transpl; 2014 May; 25(3):697-702. PubMed ID: 24821181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study.
    Tsakiris DJ; Stel VS; Finne P; Fraser E; Heaf J; de Meester J; Schmaldienst S; Dekker F; Verrina E; Jager KJ
    Nephrol Dial Transplant; 2010 Apr; 25(4):1200-6. PubMed ID: 20037169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal replacement therapy in patients with diabetes and end-stage renal disease.
    Locatelli F; Pozzoni P; Del Vecchio L
    J Am Soc Nephrol; 2004 Jan; 15 Suppl 1():S25-9. PubMed ID: 14684667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival trends in ESRD patients compared with the general population in the United States.
    van Walraven C; Manuel DG; Knoll G
    Am J Kidney Dis; 2014 Mar; 63(3):491-9. PubMed ID: 24210591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality achievement and disease prevalence in primary care predicts regional variation in renal replacement therapy (RRT) incidence: an ecological study.
    Dhoul N; de Lusignan S; Dmitrieva O; Stevens P; O'Donoghue D
    Nephrol Dial Transplant; 2012 Feb; 27(2):739-46. PubMed ID: 21677297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-years trends in renal replacement therapy for end-stage renal disease in mainland France: Lessons from the French Renal Epidemiology and Information Network (REIN) registry.
    Vigneau C; Kolko A; Stengel B; Jacquelinet C; Landais P; Rieu P; Bayat S; Couchoud C;
    Nephrol Ther; 2017 Jun; 13(4):228-235. PubMed ID: 28161264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.